SCHEMBL3671939

SCHEMBL3671939

CCCc1n[nH]c2c(=O)[nH]c(Cc3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 19/20 0.55
PDE1A P54750 3/20 0.55
PDE1B Q01064 3/20 0.55
PDE1C Q14123 3/20 0.55
PDE4B Q07343 2/20 0.55
PDE3B Q13370 2/20 0.55
PDE3A Q14432 2/20 0.55
ABCC4 O15439 2/20 0.55
PDE2A O00408 1/20 0.55
ABCC5 O15440 1/20 0.55
PDE6D O43924 1/20 0.55
PDE8A O60658 1/20 0.55
PDE9A O76083 1/20 0.55
ABCB11 O95342 1/20 0.55
CYP3A4 P08684 1/20 0.55
HTR1A P08908 1/20 0.55
PDE6A P16499 1/20 0.55
PDE6G P18545 1/20 0.55
PDE4A P27815 1/20 0.55
ADORA2A P29274 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4653201 0.92 PDE5A (0.47) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL5988676 0.92 PDE5A (0.48) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL6846835 0.91 PDE5A (0.51) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL15264061 0.88 PDE5A (0.54) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL16972377 0.88 PDE5A (0.44) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL970 0.85 PDE5A (0.74) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL6850973 0.85 PDE5A (0.48) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL20595295 0.82 PDE5A (0.49) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL7019558 0.82 PARP1 (0.41) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL16972379 0.82 PDE5A (0.41) PDE5APDE1APDE1BPDE1CPDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2825208-B1 P75NTR NEUROTROPHIN BINDING PROTEIN FOR THERAPEUTIC USE LEVICEPT LTD (GB) 2017-05-17 EP claimed
EP-2556820-A2 COMPOSITION CONTAINING PDE5 INHIBITOR FOR RELIEVING SKIN WRINKLES SK Chemicals, Co., Ltd. (KR) 2013-02-13 EP claimed
WO-2017168174-A1 NEW PHARMACEUTICAL FORMS OF SILDENAFIL N4 PHARMA UK LIMITED (GB) 2017-10-05 WO disclosed
EP-2556820-A2 COMPOSITION CONTAINING PDE5 INHIBITOR FOR RELIEVING SKIN WRINKLES SK Chemicals, Co., Ltd. (KR) 2013-02-13 EP disclosed
EP-2240467-A1 AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME Renovis, Inc. (US) 2010-10-20 EP disclosed
WO-2009089057-A1 AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME RENOVIS, INS. (US) 2009-07-16 WO disclosed
EP-2024272-A2 AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME Renovis, Inc. (US) 2009-02-18 EP disclosed
EP-1868590-A2 METHOD OF INCREASING TESTOSTERONE AND RELATED STEROID CONCENTRATIONS IN WOMEN Unimed Pharmaceuticals, Inc. (US) 2007-12-26 EP disclosed
WO-2007133637-A2 AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME RENOVIS, INC. (US) 2007-11-22 WO disclosed
US-20070154533-A1 Method of increasing testosterone and related steriod concentrations in women UNIMED PHARMACEUTICALS, LLC 2007-07-05 US disclosed
WO-2006113242-A2 METHOD OF INCREASING TESTOSTERONE AND RELATED STEROID CONCENTRATIONS IN WOMEN UNIMED PHARMACEUTICALS, INC. (US) 2006-10-26 WO disclosed